← Back to Search

CBTI plus taper method A for Insomnia (SWITCH Trial)

N/A
Waitlist Available
Led By Constance H Fung, MD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after treatment ends (which is an average of 8 months from randomization)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new method to help older Veterans stop using sleeping pills. The new method combines a gradual reduction in pill dosage with therapy to improve sleep habits. The goal is to see if this approach is better than the usual method in reducing pill use and improving sleep.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after treatment ends (which is an average of 8 months from randomization)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after treatment ends (which is an average of 8 months from randomization) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Insomnia Severity Index Score
Rates of Hypnotic Discontinuation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CBTI plus Taper method AExperimental Treatment1 Intervention
Participants in this arm will receive Cognitive Behavioral Therapy for Insomnia (CBTI) plus the novel hypnotic tapering method.
Group II: CBTI plus Taper method BActive Control1 Intervention
Participants in this arm will receive Cognitive Behavioral Therapy for Insomnia (CBTI) plus the usual tapering method used by the VA.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBTI plus taper method A
2018
N/A
~140

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,465 Total Patients Enrolled
25 Trials studying Insomnia
4,084 Patients Enrolled for Insomnia
Constance H Fung, MD MSPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA
Constance H Fung, MD MSHSPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA

Media Library

CBTI plus taper method A Clinical Trial Eligibility Overview. Trial Name: NCT03511209 — N/A
Insomnia Research Study Groups: CBTI plus Taper method A, CBTI plus Taper method B
Insomnia Clinical Trial 2023: CBTI plus taper method A Highlights & Side Effects. Trial Name: NCT03511209 — N/A
CBTI plus taper method A 2023 Treatment Timeline for Medical Study. Trial Name: NCT03511209 — N/A
~19 spots leftby Dec 2025